{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T04:41:31Z","timestamp":1759380091372,"version":"build-2065373602"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Islet \u03b2-cell dysfunction is central to the pathophysiology of glucose metabolism disorders. Probiotic supplementation has been shown to benefit glycemic control, but existing evidence on \u03b2-cell function remains inconclusive. This meta-analysis investigated the effects of probiotic supplementation on pancreatic islet \u03b2-cell function, as assessed by the homeostasis model assessment for \u03b2-cell function (HOMA-\u03b2), in individuals with impaired glucose metabolism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted. We included randomized controlled trials (RCTs) comparing probiotics with placebo or no additional treatment in adults with abnormal glucose metabolism. Random-effects meta-analysis was performed, accounting for the potential influence of heterogeneity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twelve RCTs involving 907 participants were included. Compared with controls, probiotic supplementation significantly improved HOMA-\u03b2 (mean difference [MD]: 3.04, 95% CI: 0.23 to 5.86; <jats:italic>p<\/jats:italic>\u202f=\u202f0.03; I<jats:sup>2<\/jats:sup>\u202f=\u202f92%). However, the sensitivity analysis limited to studies with low risk of bias did not show that probiotics have a significant influence on HOMA-\u03b2 in these participants (MD: -1.31, 95% CI: \u22126.30 to 3.68, <jats:italic>p<\/jats:italic>\u202f=\u202f0.61; I<jats:sup>2<\/jats:sup>\u202f=\u202f63%). Subgroup analysis showed a significant benefit in participants with baseline HbA1c\u202f\u2265\u202f8.5% (MD: 7.05, 95% CI: 5.85 to 8.24; I<jats:sup>2<\/jats:sup>\u202f=\u202f0%), but not in those with HbA1c\u202f&amp;lt;\u202f8.5% (MD: 0.19, 95% CI: \u22121.09 to 1.46; I<jats:sup>2<\/jats:sup>\u202f=\u202f37%; <jats:italic>p<\/jats:italic> for subgroup difference &amp;lt; 0.001). Meta-regression further confirmed that higher baseline HbA1c was positively associated with greater HOMA-\u03b2 improvement (coefficient\u202f=\u202f2.91; <jats:italic>p<\/jats:italic>\u202f=\u202f0.04; adjusted R<jats:sup>2<\/jats:sup>\u202f=\u202f62.5%). Other factors, such as mean age, sex, baseline body mass index, HOMA-\u03b2, concurrent hypoglycemic treatment, or probiotic treatment duration, did not significantly affect the results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Probiotics might enhance islet \u03b2-cell function in individuals with glucose metabolism disorders, particularly among those with elevated baseline HbA1c levels. However, large-scale high-quality RCTs are needed to validate our findings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>The protocol of the meta-analysis was registered at PROSPERO with the identifier CRD420251087101.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1668470","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T04:20:44Z","timestamp":1759378844000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of probiotic supplementation on islet \u03b2-cell function in subjects with glucose metabolism disorders: a meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Mengyue","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingkang","family":"Sa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zemin","family":"Tuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.pop.2024.03.003","article-title":"Glucose disorders","volume":"51","author":"Perez","year":"2024","journal-title":"Prim Care"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000543035","article-title":"ISPAD clinical practice consensus guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4239\/wjd.v14.i3.130","article-title":"Pancreatic \u03b2-cell dysfunction in type 2 diabetes: implications of inflammation and oxidative stress","volume":"14","author":"Dludla","year":"2023","journal-title":"World J Diabetes"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3390\/ijms26052320","article-title":"Unveiling gestational diabetes: an overview of pathophysiology and management","volume":"26","author":"Mittal","year":"2025","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/biomedicines12020363","article-title":"Prediabetes and Cardiometabolic risk: the need for improved diagnostic strategies and treatment to prevent diabetes and cardiovascular disease","volume":"12","author":"Lizarzaburu-Robles","year":"2024","journal-title":"Biomedicine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Rad Biol Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1359255","DOI":"10.3389\/fendo.2024.1359255","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang","year":"2024","journal-title":"Front Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1101\/cshperspect.a040741","article-title":"Pancreatic \u03b2-cell development and regeneration","volume":"14","author":"Kerper","year":"2022","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tifs.2023.06.013","article-title":"Targeting gut microbiota and metabolism as the major probiotic mechanism\u2014an evidence-based review","volume":"138","author":"Ma","year":"2023","journal-title":"Trend Food Sci Tech"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms25116022","article-title":"Effects of probiotics on gut microbiota: an overview","volume":"25","author":"Chandrasekaran","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12967-023-04306-0","article-title":"The effects of probiotics supplementation on glycaemic control among adults with type 2 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials","volume":"21","author":"Li","year":"2023","journal-title":"J Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e3655","DOI":"10.1002\/dmrr.3655","article-title":"Probiotics, prebiotics, and synbiotics in type 1 diabetes mellitus: a systematic review and meta-analysis of clinical trials","volume":"40","author":"Moravejolahkami","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12967-022-03695-y","article-title":"The effects of probiotic administration on patients with prediabetes: a meta-analysis and systematic review","volume":"20","author":"Li","year":"2022","journal-title":"J Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/nu15061375","article-title":"The effects of probiotics\/Synbiotics on glucose and lipid metabolism in women with gestational diabetes mellitus: a Meta-analysis of randomized controlled trials","volume":"15","author":"Mu","year":"2023","journal-title":"Nutrients"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"846","DOI":"10.3390\/ijms222312846","article-title":"Gut-microbial metabolites, probiotics and their roles in type 2 diabetes","volume":"22","author":"Zhai","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/life12081187","article-title":"Probiotic mechanisms affecting glucose homeostasis: a scoping review","volume":"12","author":"Pintari\u010d","year":"2022","journal-title":"Life"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/1040841x.2023.2257776","article-title":"Probiotics for pancreatic \u03b2-cell function: from possible mechanism of action to assessment of effectiveness","volume":"50","author":"Kobyliak","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1479164109336038","article-title":"HOMA-beta in the UKPDS and ADOPT. Is the natural history of type 2 diabetes characterised by a progressive and inexorable loss of insulin secretory function? Maybe? Maybe not?","volume":"6","author":"Reaven","year":"2009","journal-title":"Diab Vasc Dis Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000365153","article-title":"Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity C-reactive protein among diabetic patients: a double-blind, randomized, controlled clinical trial","volume":"65","author":"Tajadadi","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.diabet.2016.04.009","article-title":"Effects of probiotic supplementation on glycaemic control and lipid profiles in gestational diabetes: a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Karamali","year":"2016","journal-title":"Diabetes Metab"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani","year":"2017","journal-title":"Kidney Int"},{"key":"ref23","first-page":"454","article-title":"Influence of bifid-triple viable capsules as adjuvant therapy on beta cell function and insulin-resistance in patients with newly-diagnosed type 2 diabetes mellitus","volume":"29","author":"Xie","year":"2017","journal-title":"Chin J Microecol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00592-018-1175-2","article-title":"The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial","volume":"55","author":"Kassaian","year":"2018","journal-title":"Acta Diabetol"},{"key":"ref25","first-page":"1433","article-title":"Influence of Bifidobacterium tetravaccine tables on intestinal flora and pancreaticbetacell function in patients with type 2diabetes mellitus whose blood sugar were not controlled as expected","volume":"30","author":"Zhang","year":"2018","journal-title":"Chin J Microecol."},{"key":"ref26","first-page":"680","article-title":"Regulatory effect of tetragenous viable bifidobacterium tablets adjuvant therapy on serum inflammatory factors and oxidative stress in newly diagnosed type 2 diabetic patients","volume":"32","author":"Wu","year":"2020","journal-title":"Chin J Microecol."},{"key":"ref27","first-page":"1191","article-title":"Application of triple viable bifidobacterium and conventional therapy in elderly type 2 diabetes","volume":"33","author":"Hasgova","year":"2021","journal-title":"Chin J Microecol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s13300-023-01474-6","article-title":"Probiotic for pancreatic \u03b2-cell function in type 2 diabetes: a randomized, double-blinded, placebo-controlled clinical trial","volume":"14","author":"Savytska","year":"2023","journal-title":"Diabetes Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.15586\/aei.v52i4.1101","article-title":"Effect of metformin on gut microbiota imbalance in patients with T2DM, and the value of probiotic supplementation","volume":"52","author":"Li","year":"2024","journal-title":"Allergol Immunopathol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1276642","DOI":"10.3389\/fendo.2024.1276642","article-title":"Probiotic co-supplementation with absorbent smectite for pancreatic beta-cell function in type 2 diabetes: a secondary-data analysis of a randomized double-blind controlled trials","volume":"15","author":"Savytska","year":"2024","journal-title":"Front Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-025-00649-z","article-title":"Comparative evaluation of dulaglutide alone vs. dulaglutide combined with probiotics on cardiovascular risk factors in T2DM","author":"Tian","year":"2025","journal-title":"Hormones"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref34","author":"Higgins","year":"2021"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","article-title":"A clinical update on gestational diabetes mellitus","volume":"43","author":"Sweeting","year":"2022","journal-title":"Endocr Rev"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"109219","DOI":"10.1016\/j.diabres.2022.109219","article-title":"Historical review of the diagnosis of prediabetes\/intermediate hyperglycemia: case for the international criteria","volume":"185","author":"Davidson","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/19390211.2025.2522463","article-title":"Efficacy of a probiotic combination on glycemic index and insulin resistance in adults: a systematic review and meta-analysis","volume":"22","author":"Dubey","year":"2025","journal-title":"J Diet Suppl"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12902-024-01751-w","article-title":"The effect of probiotics on gestational diabetes mellitus: an umbrella meta-analysis","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"201149","DOI":"10.1016\/j.humgen.2023.201149","article-title":"Impact of probiotics in alleviating type 2 diabetes risk in clinical trials: a meta-analysis study","volume":"35","author":"Singh","year":"2023","journal-title":"Hum Gene"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/nu12041107","article-title":"The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome","volume":"12","author":"Markowiak-Kope\u0107","year":"2020","journal-title":"Nutrients"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"111572","DOI":"10.1016\/j.mce.2022.111572","article-title":"Short chain fatty acids: microbial metabolites for gut-brain axis signalling","volume":"546","author":"O\u2019Riordan","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6632266","article-title":"Modulation of short-chain fatty acids as potential therapy method for type 2 diabetes mellitus","volume":"2021","author":"Tang","year":"2021","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"116791","DOI":"10.1016\/j.bcp.2025.116791","article-title":"When short-chain fatty acids meet type 2 diabetes mellitus: revealing mechanisms, envisioning therapies","volume":"233","author":"Xie","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1120168","DOI":"10.3389\/fnut.2023.1120168","article-title":"Enhancing intestinal barrier efficiency: a novel metabolic diseases therapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Nutr"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"578386","DOI":"10.3389\/fimmu.2021.578386","article-title":"Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body","volume":"12","author":"Cristofori","year":"2021","journal-title":"Front Immunol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41574-019-0286-3","article-title":"The role of macrophages in obesity-associated islet inflammation and \u03b2-cell abnormalities","volume":"16","author":"Ying","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/microorganisms7030067","article-title":"Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives","volume":"7","author":"Mishra","year":"2019","journal-title":"Microorganisms"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells12010184","article-title":"Probiotics mechanism of action on immune cells and beneficial effects on human health","volume":"12","author":"Mazziotta","year":"2023","journal-title":"Cells"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","article-title":"Impact of the gut microbiota on inflammation, obesity, and metabolic disease","volume":"8","author":"Boulang\u00e9","year":"2016","journal-title":"Genome Med"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/antiox14070767","article-title":"Probiotics as antioxidant strategy for managing diabetes mellitus and its complications","volume":"14","author":"Viana","year":"2025","journal-title":"Antioxidants"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2337\/diacare.19.3.278","article-title":"In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance","volume":"19","author":"Elahi","year":"1996","journal-title":"Diabetes Care"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-021-00499-1","article-title":"The promise of the gut microbiome as part of individualized treatment strategies","volume":"19","author":"Schupack","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.2337\/dc08-0097","article-title":"Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates","volume":"31","author":"Manley","year":"2008","journal-title":"Diabetes Care"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.diabet.2008.02.001","article-title":"HOMA or QUICKI: is it useful to test the reproducibility of formulas?","volume":"34","author":"Antuna-Puente","year":"2008","journal-title":"Diabetes Metab"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1668470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T04:20:46Z","timestamp":1759378846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1668470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":58,"alternative-id":["10.3389\/fnut.2025.1668470"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1668470","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1668470"}}